Top Immunology Experts 2025

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. Nicholas Klaiber is a double board-certified physician in Allergy & Immunology and Pediatrics, and the founder of Virginia Allergy Treatment Center PLLC in Richmond, VA. With more than a decade of clinical experience, Dr. Klaiber specializes in the diagnosis and management of food allergies, asthma, eczema, environmental allergies, and complex immune conditions. A regional leader in Oral Immunotherapy (OIT), Dr. Klaiber has helped hundreds of children and adults safely reduce their risk of severe reactions and reclaim their quality of life. His patient-centered approach emphasizes evidence-based care, advanced diagnostic testing, and individualized treatment plans. Dr. Klaiber has published widely in peer-reviewed medical journals throughout his career and remains active in clinical research and medical education. He has been recognized by patients and families for his compassionate, accessible care—including being named Individual Allergist Winner by Fredericksburg Parent Magazine in 2025. At Virginia Allergy Treatment Center, Dr. Klaiber is committed to expanding access to innovative, lifesaving therapies such as OIT, biologics, and infusion-based immune treatments. He regularly provides expert commentary for journalists on topics related to food allergies, anaphylaxis, asthma management, immune disorders, and emerging therapies.

*Board-Certified Family Medicine Physician (ABFM) with 14+ years clinical experience (based in Chicago, IL) *Named Castle Connolly Top Doctor (2024, 2025) *Medical Media Commentator seen on/in ABC 7, Fox 32, CBS 2, WGN 9, The Chicago Tribune , Chicago Sun Times, and Everyday Health; including a nationwide 25 interview satellite media tour (TV & radio, November 2025) *Premedical Student Mentor, Urban Bridges Medical Mentoring Program Dr. Rene is a board-certified Family Medicine physician and Fellow of the American Academy of Family Physicians (FAAFP) with 14+ years of clinical experience. She provides comprehensive primary care for Medicare-eligible patients at Oak Street Health's Avalon Park location in Chicago, specializing in chronic disease management, preventive care, healthcare equity, and access for underserved communities. After overcoming 50 medical school rejections, Dr. Rene graduated from Indiana University School of Medicine and completed residency training at Ascension Saint Joseph Hospital - Chicago. She developed the L.Y.M.I.T.S. Method—a framework for transforming limitations into your greatest strengths. She mentors aspiring physicians through the Urban Bridges Medical Mentoring Program. Dr. Rene has appeared as a medical expert on ABC 7, Fox 32, CBS 2, and WGN 9 Chicago and recently completed a 25-interview national satellite media tour. She is available for expert commentary on resilience in healthcare, medical education equity, resilience and overcoming failure, healthcare access for underserved populations, and diversity in medicine.

Dr. Boluwatife OLU Afolabi is a dental surgeon and PhD candidate in Oral Biology at the University of Minnesota School of Dentistry. His research focuses on the molecular mechanisms driving head and neck squamous cell carcinoma, particularly the role of environmental carcinogens, inflammatory signaling, and transcriptional regulation in disease initiation and progression. His work investigates pathways such as the Aryl Hydrocarbon Receptor (AHR) and S100A8/S100A9-mediated inflammatory responses using cellular and molecular models of oral epithelial transformation. He has extensive experience in cancer biology, oral pathology, toxicology, and translational biomedical research. Dr. Afolabi provides expert insight on oral cancer risk factors, environmental exposures and health, inflammation and disease mechanisms, dental-systemic health connections, and emerging directions in cancer research. He is also interested in public health implications of carcinogen exposure and prevention strategies in oral and head-and-neck disease.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

I am the Co-Founder and Chief Product Officer at Mantalys, an AI start-up based in Toulouse, France dedicated to bringing lightweight, high-performance AI solutions to biomedical image analysis. With a PhD in neuro-immunology and five years of post-doctoral research experience in tumor immunology, I bring deep biomedical expertise to the computer vision team - bridging science and technology to unlock real world insights and extract actionable intelligence from biomedical images.

I’m Dr. Sohaib Aleem, a board-certified allergist dedicated to helping individuals manage and overcome allergies, asthma, and immune-related conditions. Through personalized care and advanced treatments, my mission is to help you lead a healthier, more comfortable life. At AllergyX, we provide expert solutions for various allergy-related concerns, including seasonal allergies, food sensitivities, skin conditions, and even complex disorders like mast cell activation syndrome (MCAS). Why I Became an Allergy Doctor I chose this path because I’ve seen how allergies can impact daily life. From missed work to interrupted sleep, untreated allergies often lead to frustration and discomfort. I wanted to be part of the solution, helping people understand their symptoms and providing effective relief. My approach focuses on identifying triggers, educating patients, and offering treatments tailored to individual needs. What We Offer at AllergyX At AllergyX, we specialize in diagnosing and treating: Seasonal Allergies: Relief from pollen, mold, and dust. Food Allergies: Identifying and managing food sensitivities safely. Skin Conditions: Effective solutions for eczema, hives, and rashes. Asthma: Breathe easier with personalized asthma care. Mast Cell Activation Syndrome (MCAS): Expertise in managing this complex condition. Using cutting-edge diagnostic tools and up-to-date treatments, we provide care that goes beyond symptom management to improve your overall well-being. Our Approach to Care Here’s what you can expect from AllergyX: Accurate Testing: From skin prick tests to blood tests, we use reliable methods to pinpoint your triggers. Personalized Treatments: Every plan is tailored to your lifestyle and medical history. Education and Support: I’ll ensure you have the knowledge and tools to manage your allergies effectively. Innovative Solutions: We offer advanced therapies, including allergy shots and biologics, to help you find lasting relief. You can visit more about me at: https://www.allergyx.us/consultation

Dr. Shiv Goel, MD is a board-certified physician and the founder of Prime Vitality Care, a physician-led functional medicine and wellness clinic based in San Antonio, Texas, with telehealth services available to patients in all 50 states. Dr. Goel trained in internal medicine and functional and integrative medicine, and has spent his career building a practice model that treats the root causes of poor health rather than managing symptoms in isolation. His clinical philosophy is grounded in the understanding that hormones, metabolism, inflammation, gut health, and mental well-being are deeply interconnected systems — and that lasting health improvements require addressing all of them together. Prime Vitality Care specializes in physician-supervised GLP-1 medical weight loss programs using semaglutide and tirzepatide, bioidentical hormone replacement therapy (BHRT) for women, testosterone replacement therapy (TRT) for men, peptide therapy including Sermorelin, BPC-157, and PT-141, and comprehensive functional medicine consultations for patients with chronic fatigue, gut dysfunction, autoimmune concerns, and metabolic disease. Dr. Goel is a sought-after expert on the clinical application of GLP-1 therapies, the role of hormonal imbalance in weight resistance, and the future of physician-led telehealth medicine. He speaks regularly to the gap between what conventional medicine offers patients with metabolic dysfunction and what a root-cause, functional approach can deliver when the right diagnostics and time are applied. Through Prime Vitality Care's HIPAA-compliant telehealth platform, Dr. Goel brings the same standard of clinical depth and personalization to patients nationwide that San Antonio patients have relied on in person — with lab coordination through local Quest Diagnostics or CPL sites and all prescriptions compounded and shipped directly to patients.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Dr. Calvin Williams is a Harvard University educated, board-certified dermatologist and the owner of Dermatology Group PLLC in Bedford, Texas. He specializes in medical, cosmetic, and surgical dermatology, with particular expertise in acne, eczema, hyperpigmentation, inflammatory skin conditions, and skin of color. Dr. Williams regularly educates patients and the public on evidence-based skincare, aesthetic treatments, and dermatologic health, and he is frequently sought out for expert commentary on dermatology, wellness, and cosmetic trends.

Dr. Yoon Hang “John” Kim is a board-certified integrative medicine physician with over 20 years of clinical experience dedicated to root-cause, patient-centered care. He is widely recognized as one of the leading clinical experts on Low-Dose Naltrexone (LDN) therapy, having authored three books and more than 20 articles on the subject, and leads the LDN Support Group—a thriving community of over 7,000 members. Dr. Kim completed his Integrative Medicine Fellowship at the University of Arizona’s Andrew Weil Center for Integrative Medicine, where he trained under the mentorship of Dr. Andrew Weil as a prestigious Osher Fellow. He holds board certifications in both Preventive Medicine and Integrative/Holistic Medicine, along with certification in Medical Acupuncture from UCLA. He was also a scholarship recipient from the Institute for Functional Medicine (IFM), further deepening his expertise in functional medicine approaches to complex chronic conditions. His clinical expertise spans integrative oncology—informed by deeply personal experience supporting family members who are now cancer survivors—chronic pain management, and the treatment of complex conditions including SIBO, MCAS, and autoimmune disorders. He brings a unique combination of conventional medical rigor and evidence-based complementary therapies to every patient encounter. Dr. Kim is the founder of Direct Integrative Care, a membership-based telemedicine practice that deliberately limits enrollment to ensure deep, personalized physician-patient relationships. His practice serves patients across six states—Iowa, Illinois, Missouri, Texas, Georgia, and Florida—operating entirely outside the constraints of insurance systems to preserve clinical independence and patient-first decision-making. A featured speaker at the LDN Research Trust conferences, Dr. Kim is a passionate educator who shares his expertise through his clinical and professional websites, a YouTube channel, and educational platforms including LDNSupportGroup.com. His personal motto—“Luck favors the prepared bold”—reflects his commitment to courage, preparation, and innovation in medicine.

Dr. Shipman is a dedicated clinical dermatologist and accomplished researcher specializing in general and cosmetic dermatology, skin of color, lasers, wound healing, hair loss and hidradenitis suppurativa. With a strong educational background and a commitment to advancing the field, Dr. Shipman has made significant contributions to both patient care and scientific knowledge. Dr. Shipman earned a bachelor’s degree in biology from Morehouse College, then an M.D./Ph.D. in Immunology and Microbiology from Weill Cornell Medicine. This rigorous educational foundation has provided a unique perspective that combines clinical expertise with cutting-edge research. As part of his training, Dr. Shipman completed an Internal Medicine Preliminary Residency at Yale-New Haven Hospital followed by a Dermatology Residency and Postdoctoral Fellowship at Yale University.

Independent neuroscience researcher and founder of PinealCode.com, where I publish evidence-based articles on pineal gland health, sleep science, and supplementation. My work covers fluoride accumulation in brain tissue, melatonin biochemistry, calcification mechanisms, and supplement efficacy — all referenced against primary literature from PubMed, NIH, Nature, and BMJ. Available to comment on brain health, sleep disorders, detoxification protocols, and the science behind popular wellness claims.

As I am a medical expert for Invigor Medical, a urologist, and an MD currently completing my PhD in clinical medicine, my work bridges patient care, education, and research. I serve as a teaching assistant in surgery, where I guide and support future doctors while treating patients in everyday practice. My research focuses on oncologic urology, men’s health, and hormonal health, and I actively collaborate on international studies. Through these roles, I am dedicated to advancing evidence-based medicine, improving patient outcomes, and helping shape the future of urological care.

Dr. Jay Johannigman is a Cincinnati-based trauma surgeon with over 35 years of experience in trauma and critical care. A distinguished leader in both military and civilian medicine, he has made lasting contributions to Cincinnati’s medical landscape, most notably as the former Trauma Medical Director and Chief of the Institute of Military Medicine at the University of Cincinnati Medical Center. During his tenure, he helped shape one of the region’s most advanced trauma and acute care programs, strengthening Cincinnati's role as a center of excellence in emergency medicine. A Colonel in the U.S. Army Reserve, Dr. Johannigman has served in eight combat deployments from 2003 to 2021. His military roles have included CCAT (Critical Care Air Transport) flight surgeon, Trauma “Czar,” Deputy Commander, and Director of Clinical Services in combat hospitals. His outstanding service has been recognized with numerous military honors, including the Legion of Merit, Bronze Star, Meritorious Service Medal, and Army Commendation Medal. Dr. Johannigman also played a key role in the U.S. Air Force C-STARS (Center for Sustainment of Trauma and Readiness Skills) program, helping to train medical teams in readiness and combat casualty care. He has served as Chief Medical Officer at Knight Aerospace, contributing to the design and implementation of airborne medical evacuation systems, and strengthening the ties between military innovation and civilian emergency response. Beyond his contributions on the battlefield and in the operating room, Dr. Johannigman is a passionate educator. He serves as Professor of Surgery at the F. Edward Hebert School of Medicine at the Uniformed Services University in Bethesda, Maryland, where he helps train future generations of military and civilian physicians. Dr. Johannigman has held leadership roles nationally as well, including State Trauma Chair and Region Chief for the American College of Surgeons Committee on Trauma. He remains actively involved in key professional organizations, such as the American Association for Trauma and the American College of Surgeons.

Shyam Gajula is a Cybersecurity Professional specializing in Endpoint Security, Identity & Access Management (IAM), Zero Trust Architecture, and Cloud Security with 9+ years of experience securing enterprise and hybrid environments. He helps organizations strengthen security posture by implementing identity-centric architectures, continuous risk reduction frameworks, and compliance-focused controls across AWS, VDI, and distributed infrastructures. Shyam holds the AWS Certified Solutions Architect credential and has hands-on expertise in cloud security design, endpoint hardening, authentication frameworks (including SAML 2.0 / SSO), access governance, EDR/agent policy optimization, and secure cloud operations. His research and practical work focus on real-world defenses against modern threats, endpoint risk scoring, and identity-driven security automation. He is a published cybersecurity researcher, an international keynote speaker, and serves as a judge and evaluator for global cybersecurity awards and innovation competitions. Shyam frequently contributes to peer review panels and provides expert insights on best practices for Zero Trust adoption, cloud risk mitigation, and securing modern digital workplaces. Orcid Research Profile: https://orcid.org/0009-0001-4279-9629

Dr. Paul Durham is distinguished professor of biology and director of Missouri State University's Center for Biomedical and Life Sciences, a multidisciplinary laboratory that utilizes cellular/molecular, microbiological, biochemical and chemical techniques. A primary goal of his research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, he is studying the regulation of protein expression in cultured nerve and glial cells, human cell lines, in vivo animal models and clinical studies. A major focus of his research has been to elucidate the cellular/molecular mechanisms by which novel drugs and nutraceuticals modulate the excitability state of neurons and glial cells under pathological conditions in models of migraine, TMJ disorder and epilepsy. More recently, his laboratory has been investigating epigenetic mechanisms and changes in gut microbiota in response to changes in diet, sleep pattern, stress and chronic inflammation. Durham is frequently invited as a guest lecturer. He has authored or co-authored 80 peer-reviewed research publications, numerous book chapters and technical reports, and 160 published abstracts. He has received nearly $14 million in external grants to support his research. In addition, Durham has served on numerous National Institutes of Health (NIH) study sections and advisory boards, and is currently a reviewer for 15 different journals.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

I am a research scientist with expertise in machine learning, neuroimaging, and clinical data analysis. My work focuses on applying AI, signal processing, and multimodal data integration to EEG, MRI, and related biomedical data, with experience spanning academia, healthcare, and industry. I have developed machine learning and deep learning pipelines for neural decoding, clinical document processing, and predictive modeling, and I have published and presented research in computational neuroscience and medical AI.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.